Mario Cazzola
Mario Cazzola
Professor of Hematology, University of Pavia
Verified email at unipv.it
TitleCited byYear
A gain-of-function mutation of JAK2 in myeloproliferative disorders
R Kralovics, F Passamonti, AS Buser, SS Teo, R Tiedt, JR Passweg, ...
New England Journal of Medicine 352 (17), 1779-1790, 2005
33972005
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
DA Arber, A Orazi, R Hasserjian, J Thiele, MJ Borowitz, MM Le Beau, ...
Blood 127 (20), 2391-2405, 2016
23512016
Revised international prognostic scoring system for myelodysplastic syndromes
PL Greenberg, H Tuechler, J Schanz, G Sanz, G Garcia-Manero, F SolÚ, ...
Blood 120 (12), 2454-2465, 2012
14852012
Somatic mutations of calreticulin in myeloproliferative neoplasms
KR Klampfl T, Gisslinger H, Harutyunyan AS, Nivarthi
New England Journal of Medicine 369 (25), 2379-2390, 2013
12962013
Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes
L Malcovati, U Germing, A Kuendgen, MG Della Porta, C Pascutto, ...
Journal of clinical oncology 25 (23), 3503-3510, 2007
9932007
Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making
L Malcovati, MGD Porta, C Pascutto, R Invernizzi, M Boni, E Travaglino, ...
Journal of Clinical Oncology 23 (30), 7594-7603, 2005
8782005
Clinical and biological implications of driver mutations in myelodysplastic syndromes
E Papaemmanuil, M Gerstung, L Malcovati, S Tauro, G Gundem, ...
Blood 122 (22), 3616-3627, 2013
8482013
Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts
E Papaemmanuil, M Cazzola, J Boultwood, L Malcovati, P Vyas, D Bowen, ...
New England Journal of Medicine 365 (15), 1384-1395, 2011
8212011
Retinoic acid and arsenic trioxide for acute promyelocytic leukemia
F Lo-Coco, G Avvisati, M Vignetti, C Thiede, SM Orlando, S Iacobelli, ...
New England Journal of Medicine 369 (2), 111-121, 2013
7122013
A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research andá…
F Passamonti, F Cervantes, AM Vannucchi, E Morra, E Rumi, A Pereira, ...
Blood 115 (9), 1703-1708, 2010
5792010
Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemia
F Passamonti, E Rumi, E Pungolino, L Malabarba, P Bertazzoni, ...
The American journal of medicine 117 (10), 755-761, 2004
4432004
Mutations and prognosis in primary myelofibrosis
AM Vannucchi, TL Lasho, P Guglielmelli, F Biamonte, A Pardanani, ...
Leukemia 27 (9), 1861, 2013
4342013
Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet
L Malcovati, E Hellstr÷m-Lindberg, D Bowen, L AdŔs, J Cermak, ...
Blood 122 (17), 2943-2964, 2013
4072013
JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes
E Rumi, D Pietra, V Ferretti, T Klampfl, AS Harutyunyan, JD Milosevic, ...
Blood 123 (10), 1544-1551, 2014
4052014
Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study
A Tefferi, E Rumi, G Finazzi, H Gisslinger, AM Vannucchi, F Rodeghiero, ...
Leukemia 27 (9), 1874, 2013
3622013
Myelodysplastic syndromes—coping with ineffective hematopoiesis
M Cazzola, L Malcovati
N Engl J Med 352 (6), 536-538, 2005
3542005
Use of recombinant human erythropoietin outside the setting of uremia
M Cazzola, F Mercuriali, C Brugnara
Blood 89 (12), 4248-4267, 1997
3471997
A randomized phase 3 study of lenalidomide versus placebo in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with del5q
P Fenaux, A Giagounidis, D Selleslag, O Beyne-Rauzy, G Mufti, ...
Blood 118 (14), 3765-3776, 2011
3372011
Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms
L Malcovati, E Papaemmanuil, DT Bowen, J Boultwood, MG Della Porta, ...
Blood 118 (24), 6239-6246, 2011
3332011
Blunted erythropoietin production and defective iron supply for erythropoiesis as major causes of anaemia in patients with chronic heart failure
C Opasich, M Cazzola, L Scelsi, S De Feo, E Bosimini, R Lagioia, O Febo, ...
European heart journal 26 (21), 2232-2237, 2005
3182005
The system can't perform the operation now. Try again later.
Articles 1–20